Bristol Myers Squibb (BMY) EPS (Diluted) (2009 - 2026)
Bristol Myers Squibb (BMY) posted EPS (Diluted) of $1.62 for Q2 2026, up 152.0% from $0.64 a year earlier and up 23.8% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) EPS (Diluted) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EPS (Diluted) at Bristol Myers Squibb was $4.53, up 82.9% year-over-year; for FY2025, it was $3.46.
- In prior years, Bristol Myers Squibb's EPS (Diluted) was -$4.41 in FY2024, $3.86 in FY2023 (+31.0%), $2.95 in FY2022 (-5.4%) and $3.12 in FY2021.
- The Q2 2026 figure stands as the highest quarterly EPS (Diluted) since Q4 2009.
- On a year-over-year basis, EPS (Diluted) increased in three of the last six quarters, with growth averaging 14.5%.
- The strongest year-over-year quarter for EPS (Diluted) in the past five years was Q2 2026, with growth of 152.0%; the weakest was Q4 2024, with a decline of 95.8%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was $1.31 (Q1 2026), $0.53 (Q4 2025) and $1.08 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,141.50 Bn | 1,110.09 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 622.67 Bn | 541.20 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 506.31 Bn | 479.43 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 365.39 Bn | 319.77 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 295.52 Bn | 259.51 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 259.13 Bn | 232.82 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 231.97 Bn | 187.36 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 193.85 Bn | 168.05 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 170.71 Bn | 117.36 Bn | 10.94 Bn | -0.04 |
| 10 | Bristol Myers Squibb | 123.42 Bn | 74.69 Bn | 9.25 Bn | 1.62 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 |
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 1.08 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 1.20 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.83 |
| Mar 31, 2024 | -5.89 |
| Dec 31, 2023 | 0.85 |
| Sep 30, 2023 | 0.93 |
| Jun 30, 2023 | 0.99 |
| Mar 31, 2023 | 1.07 |
| Dec 31, 2022 | 0.94 |
| Sep 30, 2022 | 0.75 |
| Jun 30, 2022 | 0.66 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 1.06 |
| Sep 30, 2021 | 0.69 |
API Access
Bristol Myers Squibb EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();